FIRALIS S.A.

FIRALIS SA :
Firalis is a biotechnology company active in discovery, development and qualification of biomarkers (BM), particularly in the Cardiovascular but also Neurology and Oncology fields through its affiliates, for applications in pre-clinical and clinical stages, such as :

• Specific BM signatures of potential toxicology effects on drugs candidates
• Patient stratification: responders/non-responders to given treatments
• Predictive BM discovery for Diagnostic, Theranostic and risk prediction applications

LOCATION :
Firalis is located mainly in Huningue, France (Basel neighbourhood, at the heart of BioValley and just on the triple border of France, Germany and Switzerland). Firalis and Firalis'​ affiliates also have locations in Paris area (Sacley-CEA and Evry-Génopole) and Strasbourg (SEMIA-Academie) as well.

ACTIVITIES :

1) BIOMARKER PRODUCTS
Firalis develops BM-based diagnostic and prognostic tools:
● RUO Kits (Research-Use-Only), based on validated innovative BMs.
● IVD Tools (In Vitro Diagnostic), based on a combination of clinically qualified BMs.

2) BIOMARKER R&D
● Development of proprietary BMs
- Cardiovascular, Safety, Inflammatory and Neurology BMs
- Renovascular Safety BMs
● Drug Safety & Drug Efficacy
● Patient Stratification
● Personalized Medicine

3) BIOMARKER SERVICES
BM Discovery for laboratories, biotechs and pharmaceutical industry:
- Proteomics
- Genomics/Transcriptomics
- Metabolomics/Lipidomics
- Flow Cytometry
- Assay development and validation
- GMP manufacturing of assay kits
- Biobanking
- Data analysis
- Consultancy

CONTACT :
Sales : +33 (0) 389 910 111 ; sales@firalis.com
Finance : +33 (0) 389 911 320 ; finance@firalis.com

FOLLOW US ON SOCIAL MEDIA :

Facebook : www.facebook.com/FIRALIS.SAS
Twitter : https://twitter.com/FiralisGroup

For all other Qs incl. distributorship : contact@firalis.com

Specialties : 

Status: 

Operating

Industries: 

Employee Count Range: 

51-200

Company type: 

Privately Held

Founded year: 

2008

Share this page